Doravirine (Pifeltro)

Published October 08, 2018; Updated November 05, 2018
Susa Coffey, MD
Selected Reference
3. Molina JM, Squires K, P. Sax, et al. Doravirine (DOR) versus ritonavir-boosted darunavir (DRV+r): 96-week results of the randomized, double-blind, phase 3 DRIVE-FORWARD noninferiority trial. In: Program and abstracts of the 22nd International AIDS Conference; July 23-27, 2018; Amsterdam. Abstract LBPEB017.